Sort
17,054 grants matching “genome editing”
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$575,237Joseph C Wu · Stanford University · R01 · FY2020 · HL
Genetics and genomics of schistosome resistance in snails
$575,206Si-Ming Zhang · University Of New Mexico · R01 · FY2022 · AI
Macrophages and attenuation of inflammation resolution in APOL1 nephropathy
$575,062Jennie J Lin · Northwestern University At Chicago · R01 · FY2022 · DK
Molecular Markers for Tumors Associated with Extrachromosomal HPV
$575,045Akinyemi Ifedapo Ojesina · Medical College Of Wisconsin · R01 · FY2025 · CA
Directed evolution of a sequence-specific targeting technology for therapeutic gene delivery to the human genome.
$574,713Jesse Bruce Owens · University Of Hawaii At Manoa · R01 · FY2021 · EB
Long Non-Coding RNAs in Allergy
$574,570Adam Williams · Northwestern University At Chicago · R01 · FY2022 · AI
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma
$574,360Richard D Kolodner · University Of California, San Diego · R01 · FY2021 · CA
Technician Training in CRISPR-based Gene Editing
$574,327John McDowell · Delaware Technical & Community College Stanton-Newark Campus · · FY2020 · EDU
Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.
$574,292Maureen A McCall · University Of Louisville · R01 · FY2025 · EY
Research Project III: RNP-CRISPR to Treat Huntington's Disease
$574,283Niren Murthy · University Of California Berkeley · U19 · FY2024 · NS
Integrating epigenomics with DNA breathing dynamics for human non-coding disease variants
$574,235Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2023 · MH
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
$574,202Wei Li · University Of California-Irvine · R01 · FY2020 · CA
Function, composition, and mechanism of RNA splicing factories in cardiomyopathy
$574,078Charles E Murry · University Of Washington · R01 · FY2024 · HL
Unraveling the molecular interconnections between circadian rhythms and lipid metabolism
$574,021Xuemin Wang · University Of Missouri-St. Louis · R35 · FY2025 · GM
Programmable gene integration and cell engineering with CRISPR-directed integrases
$574,001Omar O Abudayyeh · Massachusetts Institute Of Technology · R01 · FY2023 · EB
Programmable gene integration and cell engineering with CRISPR-directed integrases
$574,001Omar O Abudayyeh · Massachusetts Institute Of Technology · R01 · FY2022 · EB
Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence
$573,738Sam Anthony Myers · La Jolla Institute For Immunology · R01 · FY2024 · CA
RNA editing of Transporters and Pumps
$573,544Miguel Holmgren · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Genetic Repair of Familial Hypercholesterolemia
$573,477William Raymond Lagor · Baylor College Of Medicine · R01 · FY2022 · HL
Genetic modifiers of atherosclerosis and macrophage phenotypes
$573,299Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS.
$573,069Nicholas Davidson · Washington University · R37 · FY2009 · HL
Prostate Cancer Risk Enhancers
$572,877Gerhard A Coetzee · University Of Southern California · R01 · FY2015 · CA
Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease
$572,568Michael S Breen · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Targeting GSK3B in refractory B-cell malignancies
$572,454Markus Mãschen · Yale University · R01 · FY2024 · CA
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
$572,152Alice F Tarantal · University Of California At Davis · U42 · FY2020 · OD